Practice questions

Vasopressors and Inotropes practice questions

10 vasopressors and Inotropes questions from the ICU Basics bank. Tap an answer to see whether you were right, with a rationale for every choice. Your score is at the end.

Questions reviewed by Alex G, BSN, RN, CEN, CCRN, CMC, NREMT-P · From the live ICU Basics bank · Study first: Vasopressors and Inotropes cheat sheet

Question 1 · Advanced ICU Pharmacology

A patient receives low-dose epinephrine at 0.02 mcg/kg/min. Which hemodynamic pattern is MOST expected at this dose?

  1. SVR down; cardiac output up
  2. SVR up; cardiac output down
  3. SVR down; cardiac output down
  4. SVR up; cardiac output up
Show the answer and rationale

Answer: A

  • A. Correct. At low doses, β₁ (inotropy) and β₂ (vasodilation) effects predominate, so SVR falls or changes little while cardiac output rises.
  • B. This pattern suggests a pure vasoconstrictor.
  • C. β₁ stimulation increases cardiac output, not decreases it.
  • D. At higher doses, α₁ effects raise SVR, but low doses favor β effects.

Epinephrine’s effects depend on dose. At low doses, β₁ increases heart rate and contractility, and β₂ causes vasodilation in skeletal muscle beds, so SVR may fall slightly and diastolic pressure may drop while cardiac output rises. At higher doses, α₁ vasoconstriction predominates, SVR rises, and afterload increases. This is why low-dose epinephrine is sometimes used as an inotrope, such as after cardiac surgery.

Sources: Elisha et al., Nurse Anesthesia, 7th ed.; Lehne's Pharmacology for Nursing, 12th ed.

Question 2 · Advanced ICU Pharmacology

A patient with acute pulmonary edema (BP 150/90) receives low-dose IV nitroglycerin (10 mcg/min), and dyspnea improves within minutes. At standard low doses, why does nitroglycerin mainly reduce preload?

  1. It mainly dilates the veins
  2. It causes rapid, large diuresis
  3. It is a pure arterial dilator
  4. It acts as a negative inotrope
Show the answer and rationale

Answer: A

  • A. Correct. Venodilation pools blood, reducing venous return, LV filling pressure, and pulmonary congestion.
  • B. Nitroglycerin is not a diuretic.
  • C. At low doses, nitroglycerin affects veins more than arteries. Arterial effects increase at higher doses.
  • D. Nitroglycerin does not depress contractility.

Nitroglycerin is converted to nitric oxide, which activates guanylate cyclase and raises cGMP, relaxing vascular smooth muscle. At low doses, veins are affected most, which reduces preload and myocardial oxygen demand. Higher doses dilate arteries (lowering afterload) and coronaries. It is contraindicated with recent PDE-5 inhibitor use, RV infarction, and severe AS, and tolerance develops with continuous use. Headache and hypotension are common.

Sources: Elisha et al., Nurse Anesthesia, 7th ed.; Lehne's Pharmacology for Nursing, 12th ed.

Question 3 · Simple Receptor

A patient’s dopamine infusion has been titrated up to 16 mcg/kg/min. Which receptor effect now predominates, and which adverse effect is MOST important to monitor for?

  1. D₁ renal vasodilation; polyuria
  2. β₂ vasodilation; hypotension
  3. β₁ only; sinus bradycardia
  4. α₁ constriction; limb ischemia
Show the answer and rationale

Answer: D

  • A. D₁ effects predominate at low doses (1–5 mcg/kg/min).
  • B. Dopamine has little β₂ activity at any dose.
  • C. β₁ effects (predominant at 5–10 mcg/kg/min) cause tachycardia, not bradycardia.
  • D. Correct. Above about 10 mcg/kg/min, α₁ vasoconstriction dominates. Watch for limb ischemia and tachyarrhythmias.

Dopamine effects depend on dose. At 1–5 mcg/kg/min, D₁ effects predominate (renal and splanchnic vasodilation). At 5–10 mcg/kg/min, β₁ effects predominate (inotropy and chronotropy). Above 10 mcg/kg/min, α₁ vasoconstriction predominates. Individual responses vary widely. Compared with norepinephrine, dopamine causes more tachyarrhythmias, and the Surviving Sepsis Campaign recommends norepinephrine first-line.

Sources: Elsevier's 2025 Intravenous Medications; AACN Essentials of Critical Care, 5th ed.

Question 4 · Simple Receptor

A patient in status asthmaticus is on continuous nebulized albuterol. BP and perfusion are normal, but lactate has risen from 1.8 to 4.6 mmol/L, glucose is 212 mg/dL, and potassium is 3.1 mEq/L. Which explanation is MOST likely?

  1. Respiratory muscle fatigue and CO₂ retention
  2. β₂-driven glycolysis and K⁺ shift into cells
  3. Tissue hypoperfusion from early, unrecognized shock
  4. α₁ vasoconstriction causing gut ischemia
Show the answer and rationale

Answer: B

  • A. Fatigue and CO₂ retention cause respiratory acidosis, not this combination of high lactate, high glucose, and low potassium.
  • B. Correct. β₂ stimulation increases glycogenolysis and glycolysis, producing lactate and glucose, and shifts potassium into cells.
  • C. Perfusion and BP are normal, so type A (hypoperfusion) lactic acidosis is less likely.
  • D. Albuterol is not an α₁ agonist.

High-dose β₂ agonists cause a type B lactic acidosis through increased glycolysis and pyruvate production, along with hyperglycemia and hypokalemia (Na⁺/K⁺-ATPase activation). The rising lactate can be mistaken for worsening shock or respiratory failure, but it usually resolves as the β₂ agonist is weaned. The nurse still assesses perfusion, work of breathing, and blood gases to exclude fatigue and hypoperfusion, and replaces potassium.

Sources: Vincent, Textbook of Critical Care, 8th ed.; Mosby's 2026 Nursing Drug Reference

Question 5 · Pharmacological Receptors

At the cellular level, how does β₁ receptor stimulation increase myocardial contractility?

  1. It inhibits PDE-3, preventing cGMP breakdown
  2. Gq → IP₃ → mitochondrial calcium release
  3. It acts as a ligand-gated sodium channel
  4. Gs → cAMP → PKA → more calcium entry
Show the answer and rationale

Answer: D

  • A. PDE-3 inhibition describes milrinone, and it involves cAMP, not cGMP.
  • B. β₁ receptors couple to Gs, not Gq.
  • C. β₁ receptors are G-protein–coupled, not ion channels.
  • D. Correct. PKA phosphorylates L-type calcium channels and phospholamban, increasing calcium cycling.

β₁ activation stimulates adenylyl cyclase through Gs, raising cAMP and activating PKA. PKA phosphorylates L-type calcium channels (more calcium entry and contraction force), ryanodine receptors, and phospholamban (faster calcium reuptake and relaxation, called lusitropy). It also increases the SA node’s rate of spontaneous depolarization, raising heart rate. These effects increase output and myocardial oxygen demand.

Sources: Lehne's Pharmacology for Nursing, 12th ed.; Banasik, Pathophysiology, 7th ed.

Question 6 · Advanced ICU Pharmacology

A patient in cardiogenic shock with a MAP of 58 starts dobutamine 5 mcg/kg/min. Ten minutes later, the MAP falls to 48 while HR rises to 118. Which action is MOST appropriate?

  1. Stop all inotropes and give a 2 L fluid bolus
  2. Double the dobutamine to improve output
  3. Give esmolol to slow the heart rate
  4. Add norepinephrine to support vascular tone
Show the answer and rationale

Answer: D

  • A. A large bolus in cardiogenic shock risks pulmonary edema, and stopping support may worsen output.
  • B. A higher dose would increase vasodilation and tachycardia.
  • C. β-blockade would further depress a failing heart.
  • D. Correct. Dobutamine’s β₂ vasodilation lowered SVR, and norepinephrine restores tone while preserving inotropic support.

Dobutamine is an inodilator: β₁ increases contractility, and β₂ vasodilation lowers SVR. In a hypotensive patient whose cardiac output cannot rise enough, BP may fall. Current practice in cardiogenic shock often starts with norepinephrine for perfusion pressure and adds an inotrope as needed. The nurse monitors MAP, perfusion markers, arrhythmias, and ischemia.

Sources: Jacobson, CV Nursing Practice, 3rd ed.; ACC Cardiogenic Shock Guidance (2025)

Question 7 · Vasopressors & Inotropes

Norepinephrine is started for a patient in septic shock after initial fluids. Which hemodynamic response is MOST expected?

  1. MAP and SVR rise; CO is maintained or rises
  2. SVR falls; cardiac output rises markedly
  3. MAP rises; CO falls sharply with reflex bradycardia
  4. MAP is unchanged; heart rate rises markedly
Show the answer and rationale

Answer: A

  • A. Correct. Strong α₁ plus moderate β₁ activity raises SVR while preserving output, and venoconstriction increases venous return.
  • B. This is the profile of inodilators such as dobutamine or isoproterenol.
  • C. This pattern is more typical of pure α₁ agonists such as phenylephrine.
  • D. Norepinephrine has limited chronotropic effect and reliably raises MAP.

Norepinephrine is a potent α₁ agonist with moderate β₁ activity and minimal β₂ effect. In septic shock, it raises MAP and SVR, and venoconstriction increases stressed volume and venous return, so cardiac output is usually preserved or improved. Heart rate is typically unchanged or modestly increased. The Surviving Sepsis Campaign recommends it as the first-line vasopressor, and it can be started peripherally while central access is obtained.

Sources: AACN Essentials of Critical Care, 5th ed.; Elsevier's 2025 Intravenous Medications

Question 8 · Heart Failure & Cardiomyopathy

A 68-year-old woman develops chest pain and dyspnea after the sudden death of her spouse. Angiography shows nonobstructive coronaries, and the ventriculogram shows apical ballooning with a hyperkinetic base. She is now hypotensive (BP 82/50 mm Hg), and echo shows a dynamic LVOT gradient of 50 mm Hg with systolic anterior motion. Which intervention should the nurse QUESTION?

  1. Start phenylephrine if hypotension persists
  2. Give a short-acting β-blocker once perfusion allows
  3. Start a dobutamine infusion for low output
  4. Give a cautious fluid bolus to fill the LV
Show the answer and rationale

Answer: C

  • A. Appropriate. A pure vasoconstrictor raises afterload and lowers the gradient.
  • B. Appropriate. Slowing the rate and reducing contractility improve filling and reduce obstruction.
  • C. Correct. Inotropes worsen dynamic LVOT obstruction in Takotsubo with a basal hyperkinetic pattern.
  • D. Appropriate. Increasing preload enlarges the LV cavity and reduces obstruction.

Takotsubo (stress) cardiomyopathy is transient LV dysfunction, typically apical ballooning with a hypercontractile base, triggered by emotional or physical stress, most often in postmenopausal women. It mimics ACS. In some patients, basal hyperkinesis causes LVOT obstruction, and catecholamines and inotropes worsen it. Management then mirrors obstructive HCM: fluids, phenylephrine, and cautious β-blockade, with mechanical support if needed. Function usually recovers within weeks.

Sources: Ferri's Clinical Advisor 2025; Perpetua & Keegan, Cardiac Nursing, 7th ed.

Question 9 · Advanced ICU Pharmacology

A patient has received IV and then oral amiodarone for 6 days for postoperative atrial fibrillation. The patient develops a dry cough, progressive dyspnea, and SpO₂ 89% on 4 L, with new bilateral ground-glass infiltrates. The patient is afebrile. WBC and procalcitonin are normal, BNP is at baseline, the echo is unchanged, and no transfusions have been given. Which diagnosis is MOST likely?

  1. Cardiogenic pulmonary edema from worsening LV function
  2. Hospital-acquired bacterial pneumonia
  3. Amiodarone-induced pulmonary toxicity
  4. Postpericardiotomy syndrome with pleural effusions
Show the answer and rationale

Answer: C

  • A. A baseline BNP and unchanged echo argue against cardiogenic edema.
  • B. The absence of fever, leukocytosis, and elevated procalcitonin, plus bilateral ground-glass changes, makes bacterial pneumonia unlikely.
  • C. Correct. Subacute interstitial infiltrates with cough and hypoxemia, without infection or congestion, in a patient on amiodarone suggest drug toxicity.
  • D. That syndrome causes fever, pleuritic pain, and effusions rather than ground-glass infiltrates.

Amiodarone pulmonary toxicity is usually associated with long-term use, but an acute or subacute form can develop within days to weeks, especially after surgery and exposure to high FiO₂. It presents as interstitial pneumonitis or ARDS with cough, dyspnea, and hypoxemia, and it is a diagnosis of exclusion. Management is to stop amiodarone, provide oxygen support, and often give corticosteroids. The drug’s very long half-life means recovery can be slow.

Sources: Elsevier's 2025 Intravenous Medications; Mosby's 2026 Nursing Drug Reference

Question 10 · Pharmacological Receptors

What is the intracellular mechanism by which β₂ receptor activation relaxes bronchial smooth muscle?

  1. It blocks voltage-gated calcium channels directly
  2. Gs → cAMP → PKA inhibits myosin light-chain kinase
  3. Gi lowers cAMP and increases potassium efflux
  4. It competitively blocks acetylcholine at M₃
Show the answer and rationale

Answer: B

  • A. Direct calcium channel blockade is not the β₂ mechanism.
  • B. Correct. PKA inhibits myosin light-chain kinase and lowers intracellular calcium, relaxing the muscle.
  • C. β₂ receptors couple to Gs and raise cAMP.
  • D. This is the mechanism of anticholinergics such as ipratropium.

β₂ activation raises cAMP through Gs and adenylyl cyclase. PKA phosphorylates and inhibits myosin light-chain kinase, promotes calcium sequestration, and opens potassium channels, all of which relax smooth muscle. In the heart, the same pathway increases contractility, while in smooth muscle it causes relaxation, because the downstream targets differ. This explains β₂-mediated bronchodilation and vasodilation.

Sources: Lehne's Pharmacology for Nursing, 12th ed.; Rau's Resp Care Pharmacology, 11th ed.

Practice this in the app

These 10 are a sample. ICU Basics has 124 vasopressors and Inotropes questions, and it keeps your score, explains every choice and brings back the ones you miss. No ads. Pro is coming in January 2027.

Practice 124 questions in your browser

Download on theApp StoreGet it onGoogle Play

Study the topic

More practice questions

Sample questions by exam